TrialJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy2021

Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.

Anant Mohan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.